ACHE and Alzheimer disease: For example, FDA approved anti-AD drug donepezil (AChE inhibitor) can reduce AChE-induced Aβ aggregation and fibrillogenesis in vitro by binding to the peripheral anionic site (PAS) of AChE [78].